Home › Compare › YIHCF vs EQR

YIHCF vs EQR: Dividend Comparison 2026

YIHCF yields 34.75% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQR wins by $21.5K in total portfolio value· pulled ahead in Year 4
10 years
YIHCF
YIHCF
● Live price
34.75%
Share price
$0.55
Annual div
$0.19
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.3K
Annual income
$4.53
Full YIHCF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — YIHCF vs EQR

📍 EQR pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYIHCFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YIHCF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
YIHCF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YIHCF
Annual income on $10K today (after 15% tax)
$2,953.36/yr
After 10yr DRIP, annual income (after tax)
$3.85/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, EQR beats the other by $4,650.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YIHCF + EQR for your $10,000?

YIHCF: 50%EQR: 50%
100% EQR50/50100% YIHCF
Portfolio after 10yr
$37.0K
Annual income
$2,740.07/yr
Blended yield
7.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

YIHCF
No analyst data
Altman Z
3.1
Piotroski
6/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YIHCF buys
0
EQR buys
0
No recent congressional trades found for YIHCF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYIHCFEQR
Forward yield34.75% ✓5.87%
Annual dividend / share$0.19$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%15.8% ✓
Portfolio after 10y$26.3K$47.8K ✓
Annual income after 10y$4.53$5,475.61 ✓
Total dividends collected$3.9K$23.0K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: YIHCF vs EQR ($10,000, DRIP)

YearYIHCF PortfolioYIHCF Income/yrEQR PortfolioEQR Income/yrGap
1$12,437$1,737.27$11,380$679.82+$1.1K → YIHCF
2$14,318$1,009.67$13,014$837.25+$1.3K → YIHCF
3$15,863$543.14$14,961$1,036.20+$902.00 → YIHCF
4← crossover$17,255$281.20$17,297$1,289.22$42.00 → EQR
5$18,605$142.93$20,121$1,613.15$1.5K → EQR
6$19,980$72.02$23,561$2,030.84$3.6K → EQR
7$21,414$36.14$27,783$2,573.54$6.4K → EQR
8$22,931$18.10$33,013$3,284.39$10.1K → EQR
9$24,546$9.06$39,547$4,223.51$15.0K → EQR
10$26,268$4.53$47,791$5,475.61$21.5K → EQR

YIHCF vs EQR: Complete Analysis 2026

YIHCF — Stock

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.

Full YIHCF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this YIHCF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YIHCF vs SCHDYIHCF vs JEPIYIHCF vs OYIHCF vs KOYIHCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.